Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Adaptimmune
1315
Adaptimmune
Technology
Biotechnology
Adaptimmune is a multinational, clinical-stage #biotech company focused on developing novel immunotherapies that can potentially transform cancer treatment
Suggest edits
Type
B2c
Founded
2008
Raised
$42M
Follow us
Companies in the same industry
Evogene
Canexia Health
AZTherapies
Asieris Pharmaceuticals
Clinevo Technologies
Neuroelectrics
Sequenta
Northwest Biotherapeutics
Genentech
RetroSense
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Add round
11 Apr
2017
$42,000,000
Post-IPO equity
Adaptimmune Announces Closing Of 42 Million Registered Direct Offering
biospace
